Cornerstone Pharmaceutical-B (02616) granted a total of 960,000 share options and 640,000 restricted share units

Zhitongcaijing · 1d ago

Zhitong Finance App News, Cornerstone Pharmaceutical-B (02616) issued an announcement. On November 20, 2026, the board of directors resolved to grant a total of 960,000 share purchase rights to eight share option grantees in accordance with the terms of the initial public offering after-sales employee share ownership plan.

On November 20, 2026, the board of directors resolved to grant a total of 640,000 restricted share units to eight restricted share unit grantees in accordance with the terms of the restricted share award scheme after the initial public offering.